Global niche GIRS specializes in global reimbursement and market access consulting for pharmaceutical, biologics, diagnostics, medical devices, and combination products, enabling a consultative sales approach with payers and regulators to expand product market access.

Payer advocacy strength Proven payer navigation capabilities via the GIRS Payer Advocacy Compass and comprehensive services such as coding, pricing, HCPCS/CPT submissions, and coverage through payers, presenting cross-sell opportunities to manufacturers seeking faster reimbursement.

Diverse service suite End-to-end offerings from clinical trial reimbursement and health economics modeling to coverage with evidence development and formulary placement suggest opportunities to upsell bundled market access packages to existing biotech and device clients.

Global reach Strong global focus implies capacity to support multinational trials and align reimbursement strategies across regions, opening sales conversations with global biopharma and medtech companies expanding beyond the U.S. market.

Small yet strategic Small team size (2–10 employees) indicates high specialization and potential for nimble, high-touch engagements with boutique or niche manufacturers, ideal for targeted outreach and pilot programs.